Why is Marksans Pharma falling/rising?

As of 01-Aug, Marksans Pharma Ltd is experiencing a decline in its stock price, currently at 226.45, which reflects a decrease of 1.65 or 0.72%. The stock has been underperforming recently, having fallen consecutively for the last two days, resulting in a total drop of 4.21%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The stock's performance over the past week shows a slight decline of 0.68%, while its one-month return is significantly worse at -12.40%. Despite some positive factors such as high management efficiency and institutional holdings, the company faces challenges with poor long-term growth and flat results, which may be contributing to the current downward trend.
In the broader market context, the pharmaceutical sector has also seen a decline, with a drop of 3.27%, which may be influencing Marksans Pharma's performance. Compared to the benchmark Sensex, the stock has outperformed slightly in the short term, with a 1-week return of -0.68% against the Sensex's -1.06%. However, the stock's year-to-date performance is concerning, showing a decline of 23.56% while the Sensex has gained 3.15%. This stark contrast highlights the stock's struggles relative to the broader market, reinforcing the notion that investor sentiment may be negatively affected by the company's recent financial performance and market conditions.